P53 AS A POTENTIAL TARGET IN CANCER-THERAPY

被引：0
|
作者：
OZTURK, M [1 ]
PONCHEL, F [1 ]
PUISIEUX, A [1 ]
机构：
[1] HARVARD UNIV, SCH MED, BOSTON, MA 02115 USA
来源：
BONE MARROW TRANSPLANTATION | 1992年 / 9卷
关键词：
D O I：
暂无
中图分类号：
Q6 [生物物理学];
学科分类号：
071011 ;
摘要：
引用
收藏
页码：164 / 170
页数：7
相关论文
共 50 条
  • [31] P53 and induction of apoptosis as a target for anticancer therapy
    Neubauer, A
    Thiede, C
    Huhn, D
    Wittig, B
    [J]. LEUKEMIA, 1996, 10 : S2 - S4
  • [32] Role of p53 in breast cancer progression: An insight into p53 targeted therapy
    Marvalim, Charlie
    Datta, Arpita
    Lee, Soo Chin
    [J]. THERANOSTICS, 2023, 13 (04): : 1421 - 1442
  • [33] Endoplasmic reticulum (ER), a potential therapeutic target for mutant p53 colorectal cancer
    Tyagi, Ashish
    Chandrasekaran, Balaji
    Kolluru, Venkatesh
    Baby, Becca V.
    Houda, Alatassi
    Ramisetti, Srinivasa
    Sharma, Arun
    Ankem, Murali
    Damodaran, Chendil
    [J]. CANCER RESEARCH, 2019, 79 (13)
  • [34] CDC20, a potential cancer therapeutic target, is negatively regulated by p53
    T Kidokoro
    C Tanikawa
    Y Furukawa
    T Katagiri
    Y Nakamura
    K Matsuda
    [J]. Oncogene, 2008, 27 : 1562 - 1571
  • [35] CDC20, a potential cancer therapeutic target, is negatively regulated by p53
    Kidokoro, T.
    Tanikawa, C.
    Furukawa, Y.
    Katagiri, T.
    Nakamura, Y.
    Matsuda, K.
    [J]. ONCOGENE, 2008, 27 (11) : 1562 - 1571
  • [36] p53 as a target for anti-cancer immunotherapy
    Chen, HL
    Carbone, DP
    [J]. MOLECULAR MEDICINE TODAY, 1997, 3 (04): : 160 - 167
  • [37] p53 signaling in cancer progression and therapy
    Marei, Hany E.
    Althani, Asmaa
    Afifi, Nahla
    Hasan, Anwarul
    Caceci, Thomas
    Pozzoli, Giacomo
    Morrione, Andrea
    Giordano, Antonio
    Cenciarelli, Carlo
    [J]. CANCER CELL INTERNATIONAL, 2021, 21 (01)
  • [38] Cancer therapy based on p53 and Rb
    Korn, M
    [J]. EUROPEAN JOURNAL OF CANCER, 2002, 38 : S116 - S116
  • [39] p53: Prospects for cancer gene therapy
    Soddu, S
    Sacchi, A
    [J]. CYTOKINES CELLULAR & MOLECULAR THERAPY, 1998, 4 (03) : 177 - 185
  • [40] Inhibiting the p53–MDM2 interaction: an important target for cancer therapy
    Patrick Chène
    [J]. Nature Reviews Cancer, 2003, 3 : 102 - 109
12345